These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 27960133)

  • 21. Macrophage activity assessed by soluble CD163 in early rheumatoid arthritis: association with disease activity but different response patterns to synthetic and biologic DMARDs.
    Greisen SR; Møller HJ; Stengaard-Pedersen K; Hetland ML; Hørslev-Petersen K; Junker P; Østergaard M; Hvid M; Deleuran B
    Clin Exp Rheumatol; 2015; 33(4):498-502. PubMed ID: 25962601
    [TBL] [Abstract][Full Text] [Related]  

  • 22. sCD163 levels as a biomarker of disease severity in leprosy and visceral leishmaniasis.
    Silva RL; Santos MB; Almeida PL; Barros TS; Magalhães L; Cazzaniga RA; Souza PR; Luz NF; França-Costa J; Borges VM; Lima-Junior DS; Lipscomb MW; Duthie MS; Reed SG; Almeida RP; Jesus AR
    PLoS Negl Trop Dis; 2017 Mar; 11(3):e0005486. PubMed ID: 28355218
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum neopterin and soluble CD163 as markers of macrophage activation in paracetamol (acetaminophen)-induced human acute liver injury.
    Craig DG; Lee P; Pryde EA; Hayes PC; Simpson KJ
    Aliment Pharmacol Ther; 2013 Dec; 38(11-12):1395-404. PubMed ID: 24138337
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biomarkers of inflammation and axonal degeneration/damage in patients with newly diagnosed multiple sclerosis: contributions of the soluble CD163 CSF/serum ratio to a biomarker panel.
    Stilund M; Gjelstrup MC; Petersen T; Møller HJ; Rasmussen PV; Christensen T
    PLoS One; 2015; 10(4):e0119681. PubMed ID: 25860354
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changes in fat mass correlate with changes in soluble sCD163, a marker of mature macrophages, in patients with CKD.
    Axelsson J; Møller HJ; Witasp A; Qureshi AR; Carrero JJ; Heimbürger O; Bárány P; Alvestrand A; Lindholm B; Moestrup SK; Stenvinkel P
    Am J Kidney Dis; 2006 Dec; 48(6):916-25. PubMed ID: 17162146
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Soluble CD163, a unique biomarker to evaluate the disease activity, exhibits macrophage activation in systemic juvenile idiopathic arthritis.
    Sakumura N; Shimizu M; Mizuta M; Inoue N; Nakagishi Y; Yachie A
    Cytokine; 2018 Oct; 110():459-465. PubMed ID: 29801971
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Soluble CD163 made by monocyte/macrophages is a novel marker of HIV activity in early and chronic infection prior to and after anti-retroviral therapy.
    Burdo TH; Lentz MR; Autissier P; Krishnan A; Halpern E; Letendre S; Rosenberg ES; Ellis RJ; Williams KC
    J Infect Dis; 2011 Jul; 204(1):154-63. PubMed ID: 21628670
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Significance of soluble CD163 and soluble CD25 in diagnosis and treatment of children with hemophagocytic lymphohistiocytosis].
    Wang Y; Liu D; Zhu G; Yin C; Sheng G; Zhao X
    Zhonghua Er Ke Za Zhi; 2015 Nov; 53(11):824-9. PubMed ID: 26758320
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Soluble CD163.
    Møller HJ
    Scand J Clin Lab Invest; 2012 Feb; 72(1):1-13. PubMed ID: 22060747
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Macrophage activation marker soluble CD163 may predict disease progression in hepatocellular carcinoma.
    Kazankov K; Rode A; Simonsen K; Villadsen GE; Nicoll A; Møller HJ; Lim L; Angus P; Kronborg I; Arachchi N; Gorelik A; Liew D; Vilstrup H; Frystyk J; Grønbæk H
    Scand J Clin Lab Invest; 2016; 76(1):64-73. PubMed ID: 26549495
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The diagnostic significance of soluble CD163 and soluble interleukin-2 receptor alpha-chain in macrophage activation syndrome and untreated new-onset systemic juvenile idiopathic arthritis.
    Bleesing J; Prada A; Siegel DM; Villanueva J; Olson J; Ilowite NT; Brunner HI; Griffin T; Graham TB; Sherry DD; Passo MH; Ramanan AV; Filipovich A; Grom AA
    Arthritis Rheum; 2007 Mar; 56(3):965-71. PubMed ID: 17328073
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationship between monocyte/macrophage activation marker soluble CD163 and insulin resistance in obese and normal-weight subjects.
    Zanni MV; Burdo TH; Makimura H; Williams KC; Grinspoon SK
    Clin Endocrinol (Oxf); 2012 Sep; 77(3):385-90. PubMed ID: 22098563
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum levels of soluble CD163 and soluble CD14 following antibiotic therapy of patients with acute brucellosis.
    Sun H; Jiang R; Han B; Du X; Ma C; Xu Y; Chen Z; Wang L; Yang S; Lv X; Zhao H; Li X
    J Infect Dev Ctries; 2019 Aug; 13(8):714-719. PubMed ID: 32069255
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnostic and prognostic significance of cell death and macrophage activation markers in patients with hepatocellular carcinoma.
    Waidmann O; Köberle V; Bettinger D; Trojan J; Zeuzem S; Schultheiß M; Kronenberger B; Piiper A
    J Hepatol; 2013 Oct; 59(4):769-79. PubMed ID: 23792028
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CD163 expression is increased in the involved skin and sera of patients with systemic lupus erythematosus.
    Nakayama W; Jinnin M; Makino K; Kajihara I; Makino T; Fukushima S; Sakai K; Inoue Y; Ihn H
    Eur J Dermatol; 2012; 22(4):512-7. PubMed ID: 22576016
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development and application of a porcine specific ELISA for the quantification of soluble CD163.
    Pasternak JA; MacPhee DJ; Harding JCS
    Vet Immunol Immunopathol; 2019 Apr; 210():60-67. PubMed ID: 30947982
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Single-centre experience of the macrophage activation marker soluble (s)CD163 - associations with disease activity and treatment response in patients with autoimmune hepatitis.
    Grønbaek H; Kreutzfeldt M; Kazankov K; Jessen N; Sandahl T; Hamilton-Dutoit S; Vilstrup H; J Møller H
    Aliment Pharmacol Ther; 2016 Nov; 44(10):1062-1070. PubMed ID: 27679428
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Macrophage-derived soluble CD163 level in young patients with Gaucher disease: relation to phenotypes, disease severity and complications.
    Adly AAM; Ismail EAR; Ibraheem TM
    Int Immunopharmacol; 2015 Feb; 24(2):416-422. PubMed ID: 25587690
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Soluble CD163, a marker of Kupffer cell activation, is related to portal hypertension in patients with liver cirrhosis.
    Grønbaek H; Sandahl TD; Mortensen C; Vilstrup H; Møller HJ; Møller S
    Aliment Pharmacol Ther; 2012 Jul; 36(2):173-80. PubMed ID: 22591184
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of the numbers of CD163(+) cells in lesional skin and serum levels of soluble CD163 with disease progression of cutaneous T cell lymphoma.
    Sugaya M; Miyagaki T; Ohmatsu H; Suga H; Kai H; Kamata M; Fujita H; Asano Y; Tada Y; Kadono T; Okochi H; Sato S
    J Dermatol Sci; 2012 Oct; 68(1):45-51. PubMed ID: 22884782
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.